Methylphenidate (MP), a drug of choice for attention-deficit/hyperactivity disorder (ADHD), is a federally restricted substance CII in the United States because of abuse and dependence, and similar restrictions are practiced in Canada and around the world. This designation is given to drugs with medical value that present a high potential for abuse. In view of these severe restrictions, it is concerning to find out that a large group of healthy young adults, at least as large as the ADHD group of patients, take MP for cognitive enhancement, in an attempt to improve their academic achievements during studies and examinations. These young adults buy MP illegally and consume it without any medical supervision. The objective of the present debate piece is to present the ethical and clinical issues that need to be addressed in an attempt to solve this dilemma.

中文翻译：

---

哌甲酯在年轻健康成人认知增强中的应用：临床和伦理辩论。

哌甲酯 (MP) 是一种治疗注意力缺陷/多动障碍 (ADHD) 的首选药物，由于滥用和依赖，在美国属于联邦限制物质 CII，加拿大和世界各地也实行类似的限制。该名称用于具有医疗价值但具有很高滥用潜力的药物。鉴于这些严格的限制，令人担忧的是，一大群健康的年轻人，至少与 ADHD 患者一样多，服用 MP 来增强认知能力，以期提高他们在学习和学习期间的学术成就。考试。这些年轻人非法购买 MP 并在没有任何医疗监督的情况下食用。